Citations

Showing 10 of 108104 citations.

Participation in clinical trials to improve outcomes of patients with relapsed lymphoma.
Nowakowski, Grzegorz S. , Ansell, Stephen M. , Macon, William R. , Ristow, Kay M., Inwards, David J. , Johnston, Patrick B. , Klebig, Robin, Micallef, Ivana N. , Markovic, Svetomir, Porrata, Luis F. , Thompson, Carrie A. , Witzig, Thomas E. , Colgan, Joseph P. , Lin, Yi , Markovic, Svetomir N. , Habermann, Thomas M.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7523-7523

10.1200/jco.2016.34.15_suppl.7523 Get It

Outcomes in refractory aggressive diffuse large b-cell lymphoma (DLBCL): Results from the international SCHOLAR-1 study.
Crump, Michael , Neelapu, Sattva S. , Neste, Éric Van Den, Ahmed, Mohamed , Zhu, Liting , Feng, Lei, Navale, Lynn, Wiezorek, Jeffrey S., Go, William Y., Gisselbrecht, Christian , Farooq, Umar , Kuruvilla, John , Link, Brian K. , Hay, Annette E. , Cerhan, James R. , Boussetta, Sami , Maurer, Matthew J.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7516-7516

10.1200/jco.2016.34.15_suppl.7516 Get It

Prognostic significance of the proliferation signature in mantle cell lymphoma measured using digital gene expression in formalin-fixed paraffin-embedded tissue biopsies.
Wright, George W. , Slack, Graham W. , Pinyol, Magda, Boyle, Merrill, Villa, Diego , Rosenwald, Andreas , Staudt, Louis M. , Gascoyne, Randy D. , (LLMPP), on behalf of the Leukemia Lymphoma Molecular Profiling Project, Scott, David W. , Abrisqueta, Pau , Jares, Pedro , Mottok, Anja , Royo, Cristina , Clot, Guillem , Steidl, Christian , Connors, Joseph M. , Rimsza, Lisa M. , Campo, Elı́as , (LLMPP), on behalf of the Leukemia Lymphoma Molecular Profiling Project, Wright, George

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7510-7510

10.1200/jco.2016.34.15_suppl.7510 Get It

PILLAR-2: A randomized, double-blind, placebo-controlled, phase III study of adjuvant everolimus (EVE) in patients (pts) with poor-risk diffuse large B-cell lymphoma (DLBCL).
Tobinai, Kensei , Lin, Tongyu , Vanazzi, Anna , Hino, Masayuki , Shi, Yuankai , Mayer, Jiřı́ , Bermúdez, Carlos , Zhu, Jun , Bouabdallah, Kamal , Kattan, Joseph , Wu, Cassandra, Fan, Jenna, Louveau, Anne-Laure, Voi, Maurizio, Cavalli, Franco , Witzig, Thomas E. , Rigacci, Luigi , Ikeda, Takashi , Costa, Luciano J. , Belada, David

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7506-7506

10.1200/jco.2016.34.15_suppl.7506 Get It

Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): Long-term follow-up of patient-reported outcomes (PROs) in the phase III PERSIST-1 trial.
Harrison, Claire , Cervantes, Francisco , Dean, James , Wang, Lixia , Granston, Tanya, Yang, Yoojung, Mesa, Ruben A. , Vannucchi, Alessandro M. , Mead, Adam J.

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7067-7067

10.1200/jco.2016.34.15_suppl.7067 Get It

Pacritinib (PAC) vs best available therapy (BAT) in myelofibrosis (MF): 60 week follow-up of the phase III PERSIST-1 trial.
Egyed, Miklós , Szőke, Anita , Suvorov, Aleksandr , Perkins, Andrew C. , Mayer, Jiřı́ , Schouten, Harry C. , Tosi, Patrizia , Granston, Tanya, Nangalia, Jyoti , Harrison, Claire , Mesa, Ruben A. , Ganly, Peter S. , Farber, Charles Michael , Zachée, Pierre , Scheid, Christof , Dean, James P. , Kiladjian, Jean‐Jacques , Vannucchi, Alessandro M. , Mead, Adam J. , Perkins, Andrew C

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7065-7065

10.1200/jco.2016.34.15_suppl.7065 Get It

Use of revised International Prognostic Scoring System (IPSS-R) in hypocellular myelodysplastic syndromes (MDS): Mayo Clinic experience.
Cerquozzi, Sonia , Zblewski, Darci, Begna, Kebede H. , Schultz, Kirsten, Litzow, Mark R. , Al‐Kali, Aref , Alkhateeb, Hassan B. , Chen, Dong

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7063-7063

10.1200/jco.2016.34.15_suppl.7063 Get It

Treatment-free remission (TFR) in patients (pts) with chronic myeloid leukemia in chronic phase (CML-CP) treated with second-line nilotinib (NIL): First results from the ENESTop study.
Boquimpani, Carla , Kim, Dong‐Wook , Benyamini, Noam , Clementino, Nelma Cristina D., Arias, Raquel De Paz, Moiraghi, Beatriz, Nicolini, Franck E., Dengler, Jolanta, Sacha, Tomasz , Takahashi, Naoto , Fellague-Chebra, Rafik, Acharya, Sandip, Wong, Stephane, Jin, Yu , Mahon, François‐Xavier , Hughes, Timothy P. , Shuvaev, Vasily , Ailawadhi, Sikander , Lipton, Jeffrey Howard , Turkina, Anna

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7054-7054

10.1200/jco.2016.34.15_suppl.7054 Get It

Pharmacokinetics and pharmacodynamics of gilteritinib in patients with relapsed or refractory acute myeloid leukemia.
Litzow, Mark R. , Perl, Alexander E. , Altman, Jessica K. , Gill, Stan, Yuen, Geoffrey J., Bonate, Peter L. , Kadokura, Takeshi , James, Angela , Nagase, Itsuro, Fisniku, Ogert, Bahceci, Erkut, Smith, Catherine C. , Levis, Mark J. , Liu, Charles

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7026-7026

10.1200/jco.2016.34.15_suppl.7026 Get It

Long-term outcomes of ruxolitinib (RUX) therapy in patients (pts) with myelofibrosis (MF): 5-year update from COMFORT-I.
Catalano, John, Deininger, Michael W. , Miller, Carole B., Silver, Richard T. , Winton, Elliott F., Harvey, Jimmie H., Arcasoy, Murat O. , Lyons, Roger M. , Paquette, Ronald , Raza, Azra , Kornacki, Deanna , Sun, Kang , investigators, COMFORT-I, Gupta, Vikas , Verstovšek, Srđan , Mesa, Ruben A. , Gotlib, Jason , DiPersio, John F. , Talpaz, Moshe , Hexner, Elizabeth O. , Kantarjian, Hagop M. , investigators, COMFORT-I

Mayo Clinic

Journal of Clinical Oncology | September 6, 2018 | Volume: 34 | Issue: 15_suppl | Pages: 7012-7012

10.1200/jco.2016.34.15_suppl.7012 Get It